Abivax S.A. (ABVX) — Institutional Holders, Q2 2026 (page 4)
303 institutional investment managers reported a ABVX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $7.2B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 301 to 303. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
ABVX 13F holders ranked 301–303 of 303
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 301 | ROSS\JOHNSON & Associates#301 · 1 sh | 1 | $133.00 | <0.01% | New |
| 302 | Monetary Solutions, Ltd#302 · 1 sh | 1 | $133.00 | — | New |
| 303 | Clear Street Group#303 · 3,811 sh | 3,811 | $0.00 | 0.00% | New |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.